• Evaluate research advances in OMIC technologies and how they relate to MASLD care
• Describe "wet" and "dry" biomarkers and their applications in MASLD diagnosis, risk, stratisfication, and monitoring response therapy
• Identify strategies and best practices for using precision medicine to care for patients with MASLD now and into the future

Course Chairs and Faculty Disclosed the Following Relevant Financial Relationships:

• Arun Sanyal - Scientific Consultant/Advisor: Madrigal, Novo Nordisk; Research Grants: Madrigal, Novo Nordisk
• Cynthia Behling - Scientific Consultant/Advisor : Novo Nordisk
• Dina Tiniakos - Scientific Consultant/Advisor: Madrigal, Inventiva
• Kris Kowdley - Scientific Consultant/Advisor: Madrigal, Novo Nordisk; Research Grants: Madrigal, Novo Nordisk
• Mazen Noureddin - Scientific Consultant/Advisor: Madrigal, Novo Nordisk, Perspectum, Siemens, Altimmune, 89Bio, Inc., Cytodyn, Northsea Therapeutics; Research Grants: Madrigal, Novo Nordisk; Consutling for Equity: Cytodyn, ChronWell
• Meena Bansal - Scientific Consultant/Advisor: Fibronostics, Madrigal, Novo Nordisk; Research Grants: Histoindex
• Naga Chalasani - Grant/Research Support: Exact Sciences, Galectin
• Rohit Loomba - Scientific Consultant/Advisor: Altimmune, Viking Therapeutics, Metacrine, Inc., Pfizer, Inc., 89 Bio, Inc.; Research Grants: Pfizer
• Vincent Wong - Scientific Consultant/Advisor: Novo Nordisk; Commercial Speaker’s Bureau: Abbott, Novo Nordisk

All conflicts of interest were identified and any relevant relationships were mitigated prior to the activity.

The following speakers and planners disclosed no relevant financial relationships:

• Alina Allen
• Anna Mae Diehl
• Elizabeth Speilotes
• Helen Huang
• Jasmohan Bajaj
• Kathleen Corey
• Lauren Nephew
• Meagan Gray
• Norah Terrault
• Quentin Anstee
• Samer Gawrieh
• Silvia Sookoian
• Stephen Harrison
• W. Ray Kim
• Yaron Rotman
• Lucia Valenzuela-Pérez
• Allison Wing

Course Reviewers:

• Jonah Rubin, MD
• Sally Cook, AASLD LMS and Accreditation Manager
• Steve Folstein, MFA M.Ed., AASLD Vice President of Education and Professional Development

Course reviewers had no financial relationships to disclose.

Accreditation Statement: The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: AASLD designates this enduring activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification (MOC):
Successful completion of this CME activity, which includes participation in the evaluation components, enables the participant to earn up to 12.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Release Date:  March 8, 2024    Expiration Date: March 8, 2027

COPYRIGHT: All faculty in this activity have given their permission for publication 2024 AASLD.

Please review the AASLD Privacy Policy before starting the course. By enrolling in this activity you agree to the terms and conditions of this policy.